|
Aug 10
|
BioNTech Second Quarter 2025 Earnings: Revenues Disappoint
|
|
Aug 8
|
BioNTech (BNTX) Settles mRNA Patent Dispute with CureVac for US$370 Million
|
|
Aug 8
|
Top Midday Stories: Trade Desk CEO Says Tariffs Impacting Key Clients; UK Regulator Approves Boeing's Acquisition of Spirit AeroSystems
|
|
Aug 8
|
BioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
|
|
Aug 8
|
BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal
|
|
Aug 8
|
GSK to Receive $370 Million From CureVac, BioNTech Patent Dispute Settlement
|
|
Aug 8
|
GSK to be paid up to £370 million after patent row settles in US
|
|
Aug 8
|
Trending tickers: Nvidia, Intel, The Trade Desk, Pinterest and GSK
|
|
Aug 8
|
Bio/Pharmaceutical Outsourcing Analysis Report, June 2025 Edition - ADCs on the Rise: MilliporeSigma, Lonza Invest in Manufacturing While BioNTech Adds CMOs Ahead of FDA Filing
|
|
Aug 8
|
GSK to Receive $370 Million in U.S. Patent Litigation Settlement
|
|
Aug 5
|
BioNTech price target raised to $185 from $181 at Clear Street
|
|
Aug 5
|
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth
|
|
Aug 5
|
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
|
|
Aug 5
|
Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034
|
|
Aug 5
|
BioNTech SE (BNTX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...
|
|
Aug 4
|
BioNTech (BNTX) Reports Increased Sales And Reduced Losses In Q2 2025
|
|
Aug 4
|
Top Midday Stories: Berkshire Hathaway Earnings, Revenue Fall; Tesla Grants CEO Musk 96 Million New Shares
|
|
Aug 4
|
BioNTech Stock Rises as Earnings Beat Expectations. Covid-19 Vaccine Sales Helped.
|
|
Aug 4
|
Stocks Rise Pre-Bell as Traders Look to Recover Friday's Sell-Off
|
|
Aug 4
|
BioNTech's Q2 revenues double on higher COVID vaccine sales
|